Several structurally diverse hypolipidemic drugs and some widely used industrial phthalate-ester plasticiers constitute two valuable classes of xenobiotics, capable of inducing peroxisome proliferation in the hepatocytes of rodents and some non-rodent species including primates. Prolonged induction of peroxisome proliferation with these non-mutagenic and non-DNA chemicals, referred to as peroxisome proliferators, leads to the development of hepatocellular carcinomas in rats and mice. PPs are used as valuable tools to investigate the cellular, biochemical, and molecular aspects of hepatic peroxisome proliferation and hepatocarcinogenesis. The proposed hypothesis that PPs exert their pleiotropic effect by interacting with a specific binding protein(s)-(the postulated PP-receptors(s)), and that continued ligand-receptor interaction and activation of a specific set of genes leads to increased synthesis of H202-generating peroxisomal beta-oxidation enzymes, is highly attractive. The resultant PP- receptor interaction and oxidative stress caused by H202- generating beta-oxidation system are postulated to play a role in the initiation and promotion of hepatocarcinogenesis.
The specific aims of the proposed research include: 1) Synthesis of the structural analogs of clofibrate and ciprofibrate and investigation of the structure-biological activity relationship; 2) Establishing the existence of the PP-receptor(s): purification, characterization and preparation of antibodies and synthesis of ligands; 3) Further characterization of the biological, biochemical, and molecular aspects of PP-induced pleiotropic response; 4) Expression of peroxisomal catalase and beta- oxidation genes, and the selected genes of phase I activating and phase II detoxifying enzymes during the development of PP- induced hepatocellular carcinoma in the rat and to compare the biological properties of PP-induced liver tumors with those induced by classical carcinogens; and 5) The in vivo generation of free radicals and formation of hydroxyl free radical adduct of DNA in the livers of rats maintained on PPs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37GM023750-20
Application #
2174155
Study Section
Special Emphasis Panel (NSS)
Project Start
1976-06-30
Project End
1997-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
20
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Pathology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Huang, Jiansheng; Jia, Yuzhi; Fu, Tao et al. (2012) Sustained activation of PPAR? by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J 26:628-38
Vluggens, Aurore; Reddy, Janardan K (2012) Nuclear receptors and transcription factors in the development of fatty liver disease. Curr Drug Metab 13:1422-35
Bai, Liang; Jia, Yuzhi; Viswakarma, Navin et al. (2011) Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse. Hepatology 53:1164-74
Huang, Jiansheng; Viswakarma, Navin; Yu, Songtao et al. (2011) Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. Am J Pathol 179:703-13
Hall, Angela M; Brunt, Elizabeth M; Chen, Zhouji et al. (2010) Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice. J Lipid Res 51:554-63
Matsumoto, Kojiro; Huang, Jiansheng; Viswakarma, Navin et al. (2010) Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse. Carcinogenesis 31:318-25
Stumpf, Melanie; Yue, Xiaojing; Schmitz, Sandra et al. (2010) Specific erythroid-lineage defect in mice conditionally deficient for Mediator subunit Med1. Proc Natl Acad Sci U S A 107:21541-6
Vluggens, Aurore; Andreoletti, Pierre; Viswakarma, Navin et al. (2010) Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected]. Lab Invest 90:696-708
Jia, Yuzhi; Viswakarma, Navin; Fu, Tao et al. (2009) Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis. Gene Expr 14:291-306
Li, Hui; Gade, Padmaja; Nallar, Shreeram C et al. (2008) The Med1 subunit of transcriptional mediator plays a central role in regulating CCAAT/enhancer-binding protein-beta-driven transcription in response to interferon-gamma. J Biol Chem 283:13077-86

Showing the most recent 10 out of 137 publications